Answers are grounded in this paper and cite their sources.
allele interfered with the establishment of central B cell tolerance using NOD-scid-common γ chain knockout (NSG) mice engrafted with human hematopoietic stem cells expressing this allele. In contrast, the inhibition of either PTPN22 enzymatic activity or its expression by RNA interference restored defective central B cell tolerance in this model. Thus, PTPN22 blockade may represent a therapeutic strategy for the prevention or treatment of autoimmunity.
No takes yet. Share an insight, caveat, or question.
Schickel et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: